Form 8-A12B Boxed, Inc.
- S&P 500, Nasdaq post worst weeks since pandemic start as Netflix woes deepen slide
- Netflix (NFLX) Stock Plummets on Weak Guidance to Prompt Several Downgrades to Neutral
- Peloton (PTON) Shares Recover Some Losses in Pre Market After Sharing Preliminary FQ2 Results, Stifel Upgrades to Buy as 'Stock Has Over Corrected'
- Bitcoin (BTC) Price Plunges 6% to Hit 5-Month Lows
- Dollar dips with U.S. Treasury yields but still up for week; bitcoin falls
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
(Exact name of registrant as specified in its charter)
|(State of incorporation or organization)||(I.R.S. Employer Identification No.)|
New York, New York
|(Address of principal executive offices)||(Zip Code)|
Securities to be registered pursuant to Section 12(b) of the Act:
Title for each class
to be so registered
Name of each exchange on which
each class is to be registered
|Common Stock, par value $0.0001 per share||New York Stock Exchange|
|Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share||New York Stock Exchange|
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨
Securities Act registration statement file number to which this form relates: (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act: N/A
This Registration Statement on Form 8-A is being filed by Boxed, Inc. (the “Company”), formerly known as Seven Oaks Acquisition Corp., with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the transfer of the listing of the Company’s common stock, par value $0.0001 per share (“Company Common Stock”), and its warrants to purchase shares of Company Common Stock (the “Company Warrants”) from the Nasdaq Stock Market LLC to the New York Stock Exchange.
Item 1. Description of Registrant’s Securities to be Registered.
The securities to be registered hereby are the Company Common Stock and Company Warrants.
The description of the Company Warrants registered hereunder is set forth under the heading “Description of Securities” in the prospectus, dated as of December 17, 2020 (File Nos. 333-251062 and 333-251447) and filed with the SEC on December 21, 2020, and is incorporated herein by reference. The description of the Company Common Stock registered hereunder is set forth under the heading “Description of New Boxed Securities” in the definitive proxy statement / prospectus, dated as of November 9, 2021 (File No. 333-258030) and filed with the SEC on November 9, 2021, and is incorporated herein by reference.
Item 2. Exhibits.
In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the registrant are registered on the Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: December 8, 2021
|By:||/s/ Mark Zimowski|
|Name: Mark Zimowski|
|Title: Chief Financial Officer|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Hemp Doctor: Announcing a New Line of Delta 9 THC Gummies
- California American Water Asks Garrapata Area Customers to Reduce Water Use
- Landmark CIRCULATE-Japan Study Shows Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!